TSE:4506
TSE:4506Pharmaceuticals

Hematology Pipeline Advances Could Be A Game Changer For Sumitomo Pharma (TSE:4506)

In December 2025, Sumitomo Pharma America presented updated Phase 1/2 clinical data at the 67th American Society of Hematology Annual Meeting in Orlando, highlighting its investigational oral menin inhibitor enzomenib for relapsed or refractory acute leukemia and PIM1 kinase inhibitor nuvisertib for relapsed or refractory myelofibrosis. The promising response rates and favorable safety profiles reported for these two early-stage oncology candidates point to a strengthening hematology...
TSE:3157
TSE:3157Trade Distributors

Asian Dividend Stocks To Watch In December 2025

As global markets navigate the complexities of interest rate expectations and economic slowdowns, Asian indices have shown resilience, with technology and AI sectors driving gains despite broader concerns. In this environment, dividend stocks in Asia present a compelling opportunity for investors seeking steady income streams amidst market volatility.
TSE:4587
TSE:4587Biotechs

3 Asian Stocks Estimated To Be Up To 35.4% Below Intrinsic Value

As Asian markets navigate a complex economic landscape marked by fluctuating manufacturing activity and evolving monetary policies, investors are increasingly on the lookout for opportunities that may be undervalued amid these conditions. Identifying stocks that are trading below their intrinsic value can be a strategic move, offering potential for growth as market dynamics continue to shift.